Support investment and innovation in OTCs: ASMI

In its 2016 pre-Budget Submission, ASMI has proposed three regulatory reforms to incentivise investment and innovation in the non-prescription medicines sector and increase consumer access to medicines. “The non-prescription medicines sector (over-the-counter and complementary medicines) requires a regulatory framework balancing consumer protection with an operating environment that incentivises R&D, and investment in new products and